|
|
Other links at Articles > Pharmacists |
| 1. |
Infliximab and COPD: A Practice-Changing Study
|
|
|
The F1000 commentary on this practice-changing study was a major contributor to the questions on the safety of anti-tumor necrosis factor (TNF) therapies in chronic inflammatory diseases. Faculty of 1000 Medicine
|
| 2. |
Surfactant Protein D Reduced by Fluticasone in COPD
|
|
|
Although fluticasone with or without salmeterol does not alter systemic markers of inflammation in patients with COPD, the drugs do result in a significant reduction in the serum levels of the lung-specific surfactant protein D, Canadian researchers report. Reuters Health Information
|
| 4. |
Naltrexone Promising for Treating Kleptomania
|
|
|
The opiate antagonist naltrexone, commonly used to treat alcoholism and drug addiction, reduces stealing urges and behavior in kleptomania, according to study results published in the April 1st issue of Biological Psychiatry. Reuters Health Information
|
|
|
